Skip to main content
. 2014 Jun 3;289(30):20583–20593. doi: 10.1074/jbc.M114.569251

FIGURE 6.

FIGURE 6.

Protein and mRNA levels of BDK in kidneys and heart from vehicle- and BT2-treated wild-type mice. A, Western blots (top) of kidney and heart homogenates from vehicle-treated (V) and BT2-treated (T) mice with GAPDH as loading controls. The quantification of band densities shows that BDK protein levels in BT2-treated kidney and heart are reduced to 39 and 24%, respectively, compared with the vehicle-treated ones (bottom). B, BDK mRNA levels determined by quantitative PCR in kidneys from BT2-treated mice relative to the vehicle-treated ones (set as 1.0). The GAPDH mRNA level was used as an internal control. Error bars, S.D.